Özlem Kanburoğlu Meletli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Özlem Kanburoğlu Meletli has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Adnan Batman
Division of Endocrinology and Metabolism, Department of Internal Medicine, Acibadem University School of Medicine, Istanbul, Türkiye
1 shared publication - Alev Eroglu Altinova
Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Gazi University, Ankara, Turkiye
1 shared publication - Ali Saklamaz
Department of Endocrinology, Faculty of Medicine, Sifa University, Izmir, Turkey
1 shared publication - Anna Abbasgholizadeh
Marmara University School of Medicine, Department of Endocrinology and Metabolism, Istanbul, Türkiye
1 shared publication - Aysen Akalın
Osmangazi University School of Medicine, Department of Endocrinology and Metabolism, Eskisehir, Türkiye
1 shared publication - Aysen Akkurt Kocaeli
Bursa Şehir Hastanesi, Endokrinoloji ve Metabolizma Bilim Dalı, Bursa
1 shared publication
Latest Publications
- 9 March 2026
- Published by AVES YAYINCILIK A.Ş. in Endocrinology Research and Practice
Malignant-Appearing Adrenal Ganglioneuroma: Case Report of a 25-Year-Old Male with a Right Adrenal Mass
Adrenal ganglioneuromas are rare, well-differentiated tumors of sympathetic origin derived from neural crest cells. This case presents a non-functional but radiologically suspicious right adrenal mass, which was removed laparoscopically and histopathologically diagnosed as a ganglioneuroma. A 25-year-old male presented with dysuria. Abdominal magnetic resonance imaging revealed a 55 × 34 mm right adrenal mass. Ambulatory blood pressure monitoring showed no hypertension. Hormonal evaluation excluded pheochromocytoma, hyperaldosteronism, and hypercortisolism. Dehydroepiandrosterone sulfate was within the normal range. On the adrenal wash-out protocol computed tomography, the relative wash-out was −16.3% and absolute wash-out −87.5%, suggesting a non-adenomatous lesion. Laparoscopic right adrenalectomy was performed under the pre-diagnosis of a non-functional, non-adenomatous adrenal mass. Histopathological examination revealed a 6.5 × 4.7 cm ganglioneuroma. Density and wash-out parameters are insufficient to rule out malignancy in non-functional adrenal lesions. Surgical resection is appropriate for lesions ≥4 cm, with attenuation >20 Hounsfield Unit and atypical wash-out features. Following laparoscopic adrenalectomy for non-adrenocortical benign neoplasms, the prognosis is excellent, and recurrence is exceedingly rare. Cite this article as: Varlık BY, Meletli ÖK, Üçüncü Ö, Ersöz Ş. Malignant-appearing adrenal ganglioneuroma: case report of a 25-year-old male with a right adrenal mass. Endocrinol Res Pract. Published online March 2, 2026. doi: 10.5152/erp.2026.26840
- 9 March 2026
- Published by AVES YAYINCILIK A.Ş. in Endocrinology Research and Practice
Malignant-Appearing Adrenal Ganglioneuroma: Case Report of a 25-Year-Old Male with a Right Adrenal Mass
Adrenal ganglioneuromas are rare, well-differentiated tumors of sympathetic origin derived from neural crest cells. This case presents a non-functional but radiologically suspicious right adrenal mass, which was removed laparoscopically and histopathologically diagnosed as a ganglioneuroma. A 25-year-old male presented with dysuria. Abdominal magnetic resonance imaging revealed a 55 × 34 mm right adrenal mass. Ambulatory blood pressure monitoring showed no hypertension. Hormonal evaluation excluded pheochromocytoma, hyperaldosteronism, and hypercortisolism. Dehydroepiandrosterone sulfate was within the normal range. On the adrenal wash-out protocol computed tomography, the relative wash-out was −16.3% and absolute wash-out −87.5%, suggesting a non-adenomatous lesion. Laparoscopic right adrenalectomy was performed under the pre-diagnosis of a non-functional, non-adenomatous adrenal mass. Histopathological examination revealed a 6.5 × 4.7 cm ganglioneuroma. Density and wash-out parameters are insufficient to rule out malignancy in non-functional adrenal lesions. Surgical resection is appropriate for lesions ≥4 cm, with attenuation >20 Hounsfield Unit and atypical wash-out features. Following laparoscopic adrenalectomy for non-adrenocortical benign neoplasms, the prognosis is excellent, and recurrence is exceedingly rare. Cite this article as: Varlık BY, Meletli ÖK, Üçüncü Ö, Ersöz Ş. Malignant-appearing adrenal ganglioneuroma: case report of a 25-year-old male with a right adrenal mass. Endocrinol Res Pract. Published online March 2, 2026. doi: 10.5152/erp.2026.26840
- Open Access
- 16 February 2026
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 21 (1) , 37
Bone health and fracture risk in diabetes: A multicenter study
Summary: We assessed bone health in over 2500 adults with diabetes across Türkiye. T1DM patients had lower BMD, while T2DM patients showed higher fracture risk despite higher BMD. Several modifiable factors were linked to osteoporosis. These findings support personalized bone assessments in diabetic populations. Background: Diabetes mellitus (DM) is a recognized risk factor for bone fragility. While type 1 DM (T1DM) is typically associated with low bone mineral density (BMD), type 2 DM (T2DM) often presents with higher BMD despite increased fracture risk. Large-scale comparative studies remain limited. Objective: To evaluate bone health, including osteopenia, osteoporosis, and fracture risk, in adults with T1DM and T2DM. Methods: This multicenter, cross-sectional study included 2562 patients (224 with T1DM, 2338 with T2DM) from 27 centers across Türkiye. BMD was assessed using dual-energy X-ray absorptiometry (DXA) and fracture risk was estimated via the Turkish-adapted FRAX® algorithm in patients aged ≥ 40 years. Multinomial logistic regression was used to identify independent predictors of low BMD. Results: Osteoporosis prevalence was 5.5% in T1DM and 9.6% in T2DM (femoral neck T-score). Adjusted BMD was significantly lower in T1DM at all skeletal sites, while FRAX-based fracture risk and fall-related fractures were higher in T2DM. Independent predictors of osteoporosis included older age, female sex, lower BMI, reduced calcium levels, corticosteroid use, albuminuria, hypertension, and less frequent sodium-glucose cotransporter-2 (SGLT2) inhibitor use. T1DM was independently associated with osteopenia but not osteoporosis. Conclusion: This multicenter study demonstrates distinct patterns of BMD and fracture risk across diabetes subtypes and supports individualized bone health assessment in routine diabetes care.
- 16 February 2026
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 21 (1) , 37
Open AccessBone health and fracture risk in diabetes: A multicenter study
Summary: We assessed bone health in over 2500 adults with diabetes across Türkiye. T1DM patients had lower BMD, while T2DM patients showed higher fracture risk despite higher BMD. Several modifiable factors were linked to osteoporosis. These findings support personalized bone assessments in diabetic populations. Background: Diabetes mellitus (DM) is a recognized risk factor for bone fragility. While type 1 DM (T1DM) is typically associated with low bone mineral density (BMD), type 2 DM (T2DM) often presents with higher BMD despite increased fracture risk. Large-scale comparative studies remain limited. Objective: To evaluate bone health, including osteopenia, osteoporosis, and fracture risk, in adults with T1DM and T2DM. Methods: This multicenter, cross-sectional study included 2562 patients (224 with T1DM, 2338 with T2DM) from 27 centers across Türkiye. BMD was assessed using dual-energy X-ray absorptiometry (DXA) and fracture risk was estimated via the Turkish-adapted FRAX® algorithm in patients aged ≥ 40 years. Multinomial logistic regression was used to identify independent predictors of low BMD. Results: Osteoporosis prevalence was 5.5% in T1DM and 9.6% in T2DM (femoral neck T-score). Adjusted BMD was significantly lower in T1DM at all skeletal sites, while FRAX-based fracture risk and fall-related fractures were higher in T2DM. Independent predictors of osteoporosis included older age, female sex, lower BMI, reduced calcium levels, corticosteroid use, albuminuria, hypertension, and less frequent sodium-glucose cotransporter-2 (SGLT2) inhibitor use. T1DM was independently associated with osteopenia but not osteoporosis. Conclusion: This multicenter study demonstrates distinct patterns of BMD and fracture risk across diabetes subtypes and supports individualized bone health assessment in routine diabetes care.
- 1 January 2024
- Published by Galenos Yayinevi in Gazi Medical Journal
- Vol. 35 (1) , 12-18
Prevalence of Autoimmune Thyroiditis and Other Autoimmune Diseases in Relation to Serum BAFF/APRIL Levels in Prolactinoma Patients
- 1 January 2024
- Published by Galenos Yayinevi in Gazi Medical Journal
- Vol. 35 (1) , 12-18
Prevalence of Autoimmune Thyroiditis and Other Autoimmune Diseases in Relation to Serum BAFF/APRIL Levels in Prolactinoma Patients